A 14-marker blood test predicting lung cancer years before diagnosis may also identify who could benefit from anti-inflammatory prevention therapy potentially transforming how we approach lung cancer prevention. Congrats to this team!
@charlesswanton.bsky.social
www.cell.com/cell/fulltex...
A 14-protein plasma signature identifies individuals benefiting from anti-IL-1β-based
lung cancer risk reduction and demonstrates how diverse tumor-promoting factors converge
on the induction of an al...
